Treatment of myelodysplastic syndromes

N Engl J Med. 2005 May 19;352(20):2134-5; author reply 2134-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antilymphocyte Serum / adverse effects
  • Antilymphocyte Serum / therapeutic use*
  • Blood Transfusion
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Lenalidomide
  • Myelodysplastic Syndromes / drug therapy*
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use

Substances

  • Angiogenesis Inhibitors
  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Thalidomide
  • Lenalidomide